WETS
AARD

Wealth Enhancement Trust Services’s Aardvark Therapeutics AARD Stock Holding History

Wealth Enhancement Trust Services’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276 Buy
+48
New +$224 ﹤0.01% 1319

Other funds holding AARD

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Wealth Enhancement Trust Services's AARD Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Aardvark Therapeutics (AARD) in Q2 2026: 48 shares worth $276. The stake represents ﹤0.01% of the portfolio and ranks #1319 among its holdings.

9 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • Wealth Enhancement Trust Services held 48 shares of Aardvark Therapeutics worth $276 as of Q2 2026.
  • Aardvark Therapeutics was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Aardvark Therapeutics made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1319 holding.
  • 9 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.